SCHEMBL16616503

SCHEMBL16616503

COc1ccc(Nc2ncccc2C(=O)C=Cc2ccc(OC)c(OC)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
RAB9A P51151 2/20 0.58
NPSR1 Q6W5P4 2/20 0.58
NPC1 O15118 1/20 0.58
HTT P42858 1/20 0.58
PDE4A P27815 1/20 0.58
PDE4B Q07343 1/20 0.58
PDE4C Q08493 1/20 0.58
PDE4D Q08499 1/20 0.58
ABCG2 Q9UNQ0 11/20 0.57
TNFRSF1A P19438 1/20 0.57
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
MAPT P10636 2/20 0.56
GAA P10253 1/20 0.56
ABCB1 P08183 7/20 0.55
FLT3 P36888 1/20 0.55
ACHE P22303 1/20 0.55
MAOB P27338 1/20 0.55
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16616499 1.00 ALDH1A1 (0.58) ALDH1A1RAB9ANPSR1NPC1HTT
SCHEMBL16616974 0.93 ABCG2 (0.58) ALDH1A1RAB9AHTTPDE4APDE4B
SCHEMBL16616976 0.93 ABCG2 (0.58) ALDH1A1RAB9AHTTPDE4APDE4B
SCHEMBL16616840 0.92 ALDH1A1 (0.56) ALDH1A1RAB9ANPSR1NPC1HTT
SCHEMBL16616838 0.92 ALDH1A1 (0.56) ALDH1A1RAB9ANPSR1NPC1HTT
SCHEMBL16616187 0.92 ABCG2 (0.57) ALDH1A1RAB9AHTTPDE4APDE4B
SCHEMBL16616189 0.92 ABCG2 (0.57) ALDH1A1RAB9AHTTPDE4APDE4B
SCHEMBL16616480 0.92 ABCG2 (0.60) ALDH1A1RAB9ANPSR1NPC1PDE4A
SCHEMBL16616483 0.92 ABCG2 (0.60) ALDH1A1RAB9ANPSR1NPC1PDE4A
SCHEMBL16616525 0.91 ALDH1A1 (0.55) ALDH1A1RAB9ANPSR1NPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof HCCS, WEE2, WEE1 ALDH1A1 1497/4885RAB9A 1415/4885NPSR1 4735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.